Warning

Home Oxygen Therapy may be considered in adults with chronic hypoxaemia secondary to:

  • Chronic respiratory disease including:
    • COPD
    • Pulmonary Hypertension
    • Interstitial Lung Disease
  • Cardiac disease including congestive cardiac failure
  • Neuromuscular disease
  • Pulmonary malignancy

Special Considerations:

  • Palliative and End-of-Life care
  • Post-discharge patients pending formal assessment when stable
  • Smokers
  • Patients aged 16–18 years will be considered in special terms

Assessment

If considering referral for oxygen treatment, check:

  • SpO₂ on air at rest for minimum 10 minutes
  • SpO₂ when mobilising
  • Ensure reading not hindered by nail polish/gel
  • Check peripheries well perfused (use ear-lobe probe if required)
  • FBC – rule out anaemia

Primary care management

  • Optimise inhaled/cardiac therapy
  • Do not refer during acute exacerbation
  • Address reversible causes of dyspnoea
  • Provide smoking cessation advice
  • Ensure patient understands purpose and implications of home oxygen

Who to refer

Refer via SCI Gateway → Respiratory → General

Clinical Criteria

  • Patients must be optimised on maintenance therapy.
  • Patients with a resting stable Oxygen saturation (SpO2) of < 92% should be referred for an Arterial blood gas assessment to assess eligibility for Long Term Oxygen Therapy (LTOT 15-24 hrs/day).
  • In patients with clinical evidence of peripheral polycythaemia (haematocrit > 55%) or Pulmonary Hypertension, referral for LTOT assessment may be considered at SpO2 levels < 94% to identify patients with resting PaO2 < 8.0kPa.
  • Ambulatory Oxygen Therapy (AOT) assessment should be considered for patients with >4% drop below SpO2 90% that are mobile.

Required Information in Referral (SCI Gateway)

  • Primary diagnosis
  • Relevant secondary diagnoses
  • SpO₂ on air at rest (10 mins)
  • SpO₂ on mobilising
  • Date of last exacerbation (treatment completed)
  • Smoking status: Never / Current / Ex (include years stopped) / Vapes
  • Risk assessment: Lives alone, memory issues, open fires, trips/falls, mobility issues, other risks
  • Existing home oxygen: Yes/No – include details if applicable
  • Patient consent confirmed for referral and consideration of home oxygen
  • Any additional relevant clinical or social information

Who not to refer

  • Children < 18 years
  • Patients during acute exacerbation
  • Requests for oxygen solely for air travel (see 2011 BTS Guidelines)
  • Unexplained dyspnoea without alternative causes ruled out

Editorial Information

Last reviewed: 17/02/2026

Next review date: 17/02/2028

Version: 1.0

Reviewer name(s): Susan McGill.